Regulation of the nitric oxide production resulting from the glucocorticoid-insensitive expression of iNOS in human osteoarthritic cartilage

Citation
K. Vuolteenaho et al., Regulation of the nitric oxide production resulting from the glucocorticoid-insensitive expression of iNOS in human osteoarthritic cartilage, OSTEO CART, 9(7), 2001, pp. 597-605
Citations number
33
Categorie Soggetti
Rheumatology,"da verificare
Journal title
OSTEOARTHRITIS AND CARTILAGE
ISSN journal
10634584 → ACNP
Volume
9
Issue
7
Year of publication
2001
Pages
597 - 605
Database
ISI
SICI code
1063-4584(200110)9:7<597:ROTNOP>2.0.ZU;2-D
Abstract
Objective: Nitric oxide (NO) produced by cartilage and synovial membranes i s implicated in the pathogenesis of osteoarthritis (OA) and inhibitors of N O synthesis may have indications in the treatment or prevention of joint de struction in OA. Because the signaling mechanisms as well as the NOS isofor m involved in induction of NO production in human cartilage remain in many parts unclear, the present study was designed to investigate the regulation of inducible NO synthesis in human intact CA cartilage. Methods: Cartilage specimens were collected from CA patients undergoing kne e replacement surgery and studied for iNOS expression and NO production in organ culture to allow intact chondrocyte-matrix interactions. J774 macroph ages were used for comparison as a well-documented source of iNOS. Results: CA cartilage expressed iNOS and produced NO in the absence of exog enous cytokines. Addition of interleukin-1 beta (IL-1 beta), tumor necrosis factor alpha (TNF alpha) or lipopolysaccharide (LPS) into the culture medi um enhanced NO production in a dose-and time-dependent manner. Various NOS inhibitors suppressed NO production in the following order of potency: 1400 W (novel selective iNOS inhibitor)= L-NIO >L-NMMA >L-NAME. Cycloheximide (a n inhibitor of protein synthesis), pyrrolidine dithiocarbamate (PDTC; an NF -kappaB inhibitor) and genistein (an inhibitor of tyrosine protein kinases) inhibited cytokine-induced NO production, while dexamethasone, diaminohydr oxypyrimidine (DAHP; an inhibitor of tetrahydrobiopterin synthesis) and PID 98059 (p42/44 MAP kinase inhibitor) had no effect. Conclusions: The results suggest that NO synthesis in human osteoarthritic cartilage derives from the glucocorticoid-insensitive expression of iNOS. V ery similar mechanisms appear to regulate inducible NO synthesis in human o stecarthritic cartilage and J774 macrophages with the exception that dexame thasone inhibited NO production in J774 cells but not in osteoarthritic car tilage. (C) 2001 OsteoArthritis Research Society International.